[1]
Schlootz, S., Saner , F.A.M., Rabaglio, M., Imboden, S. and Wampfler, J. 2024. Feasibility and cost-effectiveness of genetic counselling for all patients with newly diagnosed ovarian cancer: a single-centre retrospective study. Swiss Medical Weekly. 154, 4 (Apr. 2024), 3386. DOI:https://doi.org/10.57187/s.3386.